Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S139000
Reexamination Certificate
active
10181943
ABSTRACT:
An objective of the present invention is to provide compounds having Rho kinase inhibitory activity. The compounds according to the present invention are those represented by formula (I) or pharmaceutically acceptable salts or solvates thereof:in-line-formulae description="In-line Formulae" end="lead"?Het—X—Z (I)in-line-formulae description="In-line Formulae" end="tail"?wherein Het represents a monocyclic or bicyclic heterocyclic group containing at least one nitrogen atom, for example, pyridyl or phthalimide; X represents group (i) —NH—C(═O)—NH—Q1-, group (ii) —NH—C(═O)—Q2-, wherein Q1 and Q2 represent a bond, alkylene, or alkenylene, or the like; and Z represents hydrogen, halogen, a monocyclic, bicyclic, or tricyclic carbocyclic group, a heterocyclic group or the like, for example, optionally substituted phenyl.
REFERENCES:
patent: 4022900 (1977-05-01), Mathison
patent: 5955496 (1999-09-01), Hammock et al.
patent: 0 168 005 (1986-01-01), None
patent: 0 277 791 (1988-08-01), None
patent: 616807 (1994-11-01), None
patent: 0 656 353 (1995-06-01), None
patent: 2 009 155 (1979-06-01), None
patent: 2020280 (1979-11-01), None
patent: 10-147585 (1998-06-01), None
patent: 11-139969 (1999-05-01), None
patent: WO 88/08424 (1988-11-01), None
patent: WO 91/17748 (1991-11-01), None
patent: WO 92/12961 (1992-08-01), None
patent: WO 94/21613 (1994-09-01), None
patent: WO 95/04045 (1995-02-01), None
patent: WO 95/07075 (1995-03-01), None
patent: WO 95/07891 (1995-03-01), None
patent: WO 95/20578 (1995-08-01), None
patent: WO 96/04266 (1996-02-01), None
patent: WO 96/24586 (1996-08-01), None
patent: WO 96/37473 (1996-11-01), None
patent: WO 97/03967 (1997-02-01), None
patent: WO 97/20833 (1997-06-01), None
patent: WO 97/44036 (1997-11-01), None
patent: WO 97/44337 (1997-11-01), None
patent: WO 97/48697 (1997-12-01), None
patent: WO 97/49399 (1997-12-01), None
patent: WO 98/06433 (1998-02-01), None
patent: WO 98/09961 (1998-03-01), None
patent: WO 98/22455 (1998-05-01), None
patent: WO 99/00357 (1999-01-01), None
patent: WO 99/16768 (1999-04-01), None
patent: WO 99/21836 (1999-05-01), None
patent: WO 99/37640 (1999-07-01), None
patent: WO 99/38867 (1999-08-01), None
patent: WO 99/64423 (1999-12-01), None
patent: WO 00/26208 (2000-05-01), None
patent: WO 00/48998 (2000-08-01), None
patent: WO 01/15677 (2001-03-01), None
Sanchez et al, Heterocyles, vol. 31, No. 11, pp. 2003-2010, 1990.
Llama et al, J. Pharm. Pharmacol, vol. 43, pp. 68-69, 1991.
J.R. Bagley et al., “New 4-(Heteroanilido)piperidines, Structurally Related to the Pure Opioid Agonist Fentanyl, with Agonist and/or Antagonist Properties,” J. Med. Chem. (1989) 32:663-671, American Chemical Society.
T. Singh et al., “Antimalarials. 7-Chloro-4-(substituted amino)quinolines,” Journal of Medicinal Chemistry (1971) 14(4):283-286.
Iijima Hiroshi
Iwakubo Masayuki
Okada Yuji
Takami Atsuya
Davis Zinna N.
Foley & Lardner LLP
Kirin Beer Kabushiki Kaisha
LandOfFree
Nitrogen-containing compounds having kinase inhibitory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrogen-containing compounds having kinase inhibitory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen-containing compounds having kinase inhibitory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3778309